Cite
HARVARD Citation
Reinisch, W. et al. (2022). Safety, pharmacokinetic, and pharmacodynamic study of sibofimloc, a novel FimH blocker in patients with active Crohn's disease. Journal of gastroenterology and hepatology. 37 (5), pp. 832-840. [Online].